Skip to main content
NCBI home page
The Western Journal of Medicine logoLink to The Western Journal of Medicine
. 1994 Jun;160(6):540–544.

Prevalence of HTLV types I and II among drug users in King County, Washington.

H Thiede 1, N V Harris 1, J P McGough 1, B Roberts 1, R F Khabbaz 1, J E Kaplan 1
PMCID: PMC1022556  PMID: 8053176

Abstract

We investigated the prevalence of human T-cell lymphotropic virus (HTLV) types I and II among drug users entering treatment in King County, Washington, between 1988 and 1990. Of 762 injection-drug users, 81 (10.6%) were HTLV-positive; of 89 noninjection-drug users, 2 (2%) were HTLV-positive. Most (95.8%) of those typed) were HTLV-II-positive. The relationship between HTLV and demographic and behavioral characteristics was further evaluated among injection-drug users. The prevalence rates for HTLV increased 25-fold from the youngest age group (15 to 24 years) to the oldest (older than 45 years), after adjusting for race. After adjustment for age, American Indians or Alaska Natives were 7.9 times, blacks 6.2 times, Asians or Pacific Islanders 4.7 times, and Hispanics 4.1 times as likely as whites to be HTLV-positive. The prevalence of HTLV among heroin injectors was more than double that observed among injectors of other drugs after adjusting for age, although this association was only marginally significant. The strong association between HTLV prevalence and age suggests that HTLV-II (the predominant virus) has been endemic among King County injection-drug users for some time. Its relatively high prevalence indicates that there is both an opportunity and a need to further investigate the epidemiologic and clinical implications of HTLV-II infection.

Full text

PDF
540

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Biggar R. J., Buskell-Bales Z., Yakshe P. N., Caussy D., Gridley G., Seeff L. Antibody to human retroviruses among drug users in three east coast American cities, 1972-1976. J Infect Dis. 1991 Jan;163(1):57–63. doi: 10.1093/infdis/163.1.57. [DOI] [PubMed] [Google Scholar]
  2. Blattner W. A., Nomura A., Clark J. W., Ho G. Y., Nakao Y., Gallo R., Robert-Guroff M. Modes of transmission and evidence for viral latency from studies of human T-cell lymphotrophic virus type I in Japanese migrant populations in Hawaii. Proc Natl Acad Sci U S A. 1986 Jul;83(13):4895–4898. doi: 10.1073/pnas.83.13.4895. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Cantor K. P., Weiss S. H., Goedert J. J., Battjes R. J. HTLV-I/II seroprevalence and HIV/HTLV coinfection among U.S. intravenous drug users. J Acquir Immune Defic Syndr. 1991;4(5):460–467. [PubMed] [Google Scholar]
  4. Cohen N. D., Muñoz A., Reitz B. A., Ness P. K., Frazier O. H., Yawn D. H., Lee H., Blattner W., Donahue J. G., Nelson K. E. Transmission of retroviruses by transfusion of screened blood in patients undergoing cardiac surgery. N Engl J Med. 1989 May 4;320(18):1172–1176. doi: 10.1056/NEJM198905043201803. [DOI] [PubMed] [Google Scholar]
  5. Feigal E., Murphy E., Vranizan K., Bacchetti P., Chaisson R., Drummond J. E., Blattner W., McGrath M., Greenspan J., Moss A. Human T cell lymphotropic virus types I and II in intravenous drug users in San Francisco: risk factors associated with seropositivity. J Infect Dis. 1991 Jul;164(1):36–42. doi: 10.1093/infdis/164.1.36. [DOI] [PubMed] [Google Scholar]
  6. Harris N. V., Thiede H., McGough J. P., Gordon D. Risk factors for HIV infection among injection drug users: results of blinded surveys in drug treatment centers, King County, Washington 1988-1991. J Acquir Immune Defic Syndr. 1993 Nov;6(11):1275–1282. [PubMed] [Google Scholar]
  7. Hartley T. M., Khabbaz R. F., Cannon R. O., Kaplan J. E., Lairmore M. D. Characterization of antibody reactivity to human T-cell lymphotropic virus types I and II using immunoblot and radioimmunoprecipitation assays. J Clin Microbiol. 1990 Apr;28(4):646–650. doi: 10.1128/jcm.28.4.646-650.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Heneine W., Kaplan J. E., Gracia F., Lal R., Roberts B., Levine P. H., Reeves W. C. HTLV-II endemicity among Guaymi Indians in Panama. N Engl J Med. 1991 Feb 21;324(8):565–565. doi: 10.1056/NEJM199102213240815. [DOI] [PubMed] [Google Scholar]
  9. Hjelle B., Scalf R., Swenson S. High frequency of human T-cell leukemia-lymphoma virus type II infection in New Mexico blood donors: determination by sequence-specific oligonucleotide hybridization. Blood. 1990 Aug 1;76(3):450–454. [PubMed] [Google Scholar]
  10. Jones T. S., Allen D. M., Onorato I. M., Petersen L. R., Dondero T. J., Jr, Pappaioanou M. HIV seroprevalence surveys in drug treatment centers. Public Health Rep. 1990 Mar-Apr;105(2):125–130. [PMC free article] [PubMed] [Google Scholar]
  11. Kajiyama W., Kashiwagi S., Ikematsu H., Hayashi J., Nomura H., Okochi K. Intrafamilial transmission of adult T cell leukemia virus. J Infect Dis. 1986 Nov;154(5):851–857. doi: 10.1093/infdis/154.5.851. [DOI] [PubMed] [Google Scholar]
  12. Kalyanaraman V. S., Sarngadharan M. G., Robert-Guroff M., Miyoshi I., Golde D., Gallo R. C. A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukemia. Science. 1982 Nov 5;218(4572):571–573. doi: 10.1126/science.6981847. [DOI] [PubMed] [Google Scholar]
  13. Khabbaz R. F., Darrow W. W., Hartley T. M., Witte J., Cohen J. B., French J., Gill P. S., Potterat J., Sikes R. K., Reich R. Seroprevalence and risk factors for HTLV-I/II infection among female prostitutes in the United States. JAMA. 1990 Jan 5;263(1):60–64. [PubMed] [Google Scholar]
  14. Khabbaz R. F., Onorato I. M., Cannon R. O., Hartley T. M., Roberts B., Hosein B., Kaplan J. E. Seroprevalence of HTLV-1 and HTLV-2 among intravenous drug users and persons in clinics for sexually transmitted diseases. N Engl J Med. 1992 Feb 6;326(6):375–380. doi: 10.1056/NEJM199202063260604. [DOI] [PubMed] [Google Scholar]
  15. Lairmore M. D., Jacobson S., Gracia F., De B. K., Castillo L., Larreategui M., Roberts B. D., Levine P. H., Blattner W. A., Kaplan J. E. Isolation of human T-cell lymphotropic virus type 2 from Guaymi Indians in Panama. Proc Natl Acad Sci U S A. 1990 Nov;87(22):8840–8844. doi: 10.1073/pnas.87.22.8840. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Lal R. B., Heneine W., Rudolph D. L., Present W. B., Hofhienz D., Hartley T. M., Khabbaz R. F., Kaplan J. E. Synthetic peptide-based immunoassays for distinguishing between human T-cell lymphotropic virus type I and type II infections in seropositive individuals. J Clin Microbiol. 1991 Oct;29(10):2253–2258. doi: 10.1128/jcm.29.10.2253-2258.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Levine P. H., Blattner W. A., Clark J., Tarone R., Maloney E. M., Murphy E. M., Gallo R. C., Robert-Guroff M., Saxinger W. C. Geographic distribution of HTLV-I and identification of a new high-risk population. Int J Cancer. 1988 Jul 15;42(1):7–12. doi: 10.1002/ijc.2910420103. [DOI] [PubMed] [Google Scholar]
  18. Levine P. H., Jacobson S., Elliott R., Cavallero A., Colclough G., Dorry C., Stephenson C., Knigge R. M., Drummond J., Nishimura M. HTLV-II infection in Florida Indians. AIDS Res Hum Retroviruses. 1993 Feb;9(2):123–127. doi: 10.1089/aid.1993.9.123. [DOI] [PubMed] [Google Scholar]
  19. MANTEL N., HAENSZEL W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959 Apr;22(4):719–748. [PubMed] [Google Scholar]
  20. Maloney E. M., Biggar R. J., Neel J. V., Taylor M. E., Hahn B. H., Shaw G. M., Blattner W. A. Endemic human T cell lymphotropic virus type II infection among isolated Brazilian Amerindians. J Infect Dis. 1992 Jul;166(1):100–107. doi: 10.1093/infdis/166.1.100. [DOI] [PubMed] [Google Scholar]
  21. Murphy E. L., Figueroa J. P., Gibbs W. N., Brathwaite A., Holding-Cobham M., Waters D., Cranston B., Hanchard B., Blattner W. A. Sexual transmission of human T-lymphotropic virus type I (HTLV-I). Ann Intern Med. 1989 Oct 1;111(7):555–560. doi: 10.7326/0003-4819-111-7-555. [DOI] [PubMed] [Google Scholar]
  22. Poiesz B. J., Ruscetti F. W., Gazdar A. F., Bunn P. A., Minna J. D., Gallo R. C. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A. 1980 Dec;77(12):7415–7419. doi: 10.1073/pnas.77.12.7415. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Reeves W. C., Cutler J. R., Gracia F., Kaplan J. E., Castillo L., Hartley T. M., Brenes M. M., Larreategui M., Loo de Lao S., Archbold C. Human T cell lymphotropic virus infection in Guaymi Indians from Panama. Am J Trop Med Hyg. 1990 Oct;43(4):410–418. doi: 10.4269/ajtmh.1990.43.410. [DOI] [PubMed] [Google Scholar]
  24. Robert-Guroff M., Weiss S. H., Giron J. A., Jennings A. M., Ginzburg H. M., Margolis I. B., Blattner W. A., Gallo R. C. Prevalence of antibodies to HTLV-I, -II, and -III in intravenous drug abusers from an AIDS endemic region. JAMA. 1986 Jun 13;255(22):3133–3137. [PubMed] [Google Scholar]
  25. Rosenblatt J. D., Golde D. W., Wachsman W., Giorgi J. V., Jacobs A., Schmidt G. M., Quan S., Gasson J. C., Chen I. S. A second isolate of HTLV-II associated with atypical hairy-cell leukemia. N Engl J Med. 1986 Aug 7;315(6):372–377. doi: 10.1056/NEJM198608073150606. [DOI] [PubMed] [Google Scholar]
  26. Wiktor S. Z., Cannon R. O., Atkinson W. L., Lutz B., Hook E. W., 3rd, Blattner W. A., Quinn T. C. Infection with human T lymphotropic virus types I and II in sexually transmitted disease clinics in Baltimore and New Orleans. J Infect Dis. 1992 May;165(5):920–924. doi: 10.1093/infdis/165.5.920. [DOI] [PubMed] [Google Scholar]
  27. Wiktor S. Z., Pate E. J., Weiss S. H., Gohd R. S., Correa P., Fontham E. T., Hanchard B., Biggar R. J., Blattner W. A. Sensitivity of HTLV-I antibody assays for HTLV-II. Lancet. 1991 Aug 24;338(8765):512–513. doi: 10.1016/0140-6736(91)90585-d. [DOI] [PubMed] [Google Scholar]

Articles from Western Journal of Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES